Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of USMD will - over the next 2 Weeks and hit - by . In that time frame, USMD's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
USMD shares remained flat 0 in Friday, September 11, 2026's trading session, starting and closing at a previous close of $30.93 to move at $30.93. The stock demonstrated notable intraday movement (see USMD's key stats for a full breakdown), fluctuating between $30.43 and $30.93, a +1.65% trading range. While recent weeks have seen some volatility, USMD has managed to secure a -0.35% drop over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 9 shares changing hands, 1 fewer than the previous session. This amounted to $278.40 in total market activity.
Will USMD Continue Its Trend?
According to analyst ratings and projections for USMD, CoreValues America First Technology ETF shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators currently suggest a bearish sentiment for USMD. However, the stock has recorded 17 positive trading days within the past 30 sessions. Based on the USMD stock forecast, now is not the best time to buy USMD stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on USMD covering social and institutional perspectives.
USMD Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into USMD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 52.41% to 54.44%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 52.92%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 55.04%, maintains a neutral outlook for the long term. Insights into USMD's shareholder base show how institutional investors are positioning themselves during these momentum shifts

